Tharun is a Chartered Financial Analyst from the CFA Institute, U.S. A graduate from Loyola College, Chennai, he started his career in Goldman Sachs at their Bangalore office. Prior to his current role at Proactive Investors, he worked as an equity analyst at a global research and analytics company in Mumbai, assisting institutional clients across Asia.
Aiming to capitalise on the pending legalisation by the Canadian Federal Government of concentrates and vaporisers in October 2019.
The company is also expanding the total leased land for its Northern NSW cannabis cultivation site up to 150,000 square metres.
Imugene’s HER-Vaxx is a B-cell peptide cancer vaccine designed to treat tumours that over-express the HER-2/neu receptor.
Medlab has two cannabis-based medicines, NanaBis™ and NanaBidial™.
Construction has commenced on Australia’s first salt-lake brine SOP production operation.
MMJ is a global cannabis investment company with a portfolio of listed and unlisted holdings.
A number of board members have purchased shares in the company in 2019 to date.
The company was recently awarded a patent for a novel prognostic biomarker for breast cancer.